Clinical Trials on Severe Burns in Singapore

Total 33 results

Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule

Dengue Fever | Dengue Hemorrhagic Fever

Singapore
Singapore General Hospital

Unknown

The Effects of Hyperbaric Oxygen Therapy (HBOT) on Acute Thermal Burns

Acute Thermal Burns

Singapore
Sanofi Pasteur, a Sanofi Company

Completed

Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Diseases

Singapore
National University Hospital, Singapore
Tan Tock Seng Hospital; Ng Teng Fong General Hospital

Completed

Prospective Study for the Evaluation of Dengue Prognostic Biomarkers in Singapore

Dengue Hemorrhagic Fever | Severe Dengue | Dengue Shock Syndrome

Singapore
Tysana Pte Ltd

Completed

Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans

Treatment of Acute Yellow Fever Virus Infection

Singapore
Singapore General Hospital
Duke-NUS Graduate Medical School; 60 Degrees Pharmaceuticals LLC

Withdrawn

Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore

Dengue Fever

Singapore
Singapore General Hospital
Duke-NUS Graduate Medical School

Completed

Celgosivir as a Treatment Against Dengue (CELADEN)

Dengue Fever

Singapore
Singapore General Hospital

Completed

Yellow Fever Vaccine on Statin/ Non Statin Subjects

Yellow Fever | Yellow Fever Vaccine

Singapore
GlaxoSmithKline

Completed

Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants

Rotavirus Severe Gastroenteritis

Singapore
Janssen Research & Development, LLC

Terminated

A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever

Dengue

Singapore
Takeda

Completed

Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in Singapore

Dengue Fever

Singapore
Changi General Hospital
Singhealth Foundation

Completed

Glutamine Supplementation in Critically Ill Patients With Severe Sepsis (CGH-GLU)

Severe Sepsis

Singapore
National University Hospital, Singapore
Singapore General Hospital; Duke-NUS Graduate Medical School

Unknown

Ketotifen as a Treatment for Vascular Leakage During Dengue Fever (KETODEN)

Dengue Fever | Pleural Effusion

Singapore
Singapore General Hospital
Duke-NUS Graduate Medical School

Completed

The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans

Encephalitis, Japanese | Yellow Fever

Singapore
Tan Tock Seng Hospital
National University Hospital, Singapore; University of Malaya; Singapore General... and other collaborators

Completed

Adult Dengue Platelet Study (ADEPT)

Dengue Fever

Malaysia, Singapore
Singapore General Hospital
Duke-NUS Graduate Medical School

Completed

Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection

Yellow Fever | Viral Infection | Endoplasmic Reticulum Stress

Singapore
Singapore General Hospital
Duke-NUS Graduate Medical School

Recruiting

An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity

Japanese Encephalitis | Infectious Disease | Yellow Fever | Viral Infection

Singapore
Changi General Hospital

Terminated

Procalcitonin in Fever of Unknown Etiology

Fever

Singapore
Alcon Research

Completed

Early Feasibility Study of UV-Femtosecond Laser Assisted Lenticular Extraction

Refractive Error - Myopia Severe | Refractive Error - Myopia Simple

United States, Ireland, Singapore
National Environment Agency, Singapore
Ministry of Health, Singapore

Recruiting

Impact of Project Wolbachia - Singapore on Dengue Incidence

Dengue

Singapore
SingHealth Polyclinics

Completed

Effects of a Serious Game on Knowledge, Attitude and Practice in Vector Control and Dengue Prevention Among Adults in Primary Care

Dengue

Singapore
Novartis

Completed

Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension

Moderate to Severe Hypertension

Russian Federation, Romania, Singapore, Spain, Germany, Philippines
Novartis Pharmaceuticals

Recruiting

A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever

Dengue

Singapore, Malaysia, India
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia

Yellow Fever

Germany, France, Finland, Singapore, Spain, Thailand
National Institute of Allergy and Infectious Diseases...
University of Oxford; Wellcome Trust; World Health Organization

Completed

High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza

Influenza | Avian Influenza | Severe Influenza

Singapore, Thailand, Vietnam
Daren K. Heyland
Canadian Institutes of Health Research (CIHR)

Active, not recruiting

The RE-ENERGIZE Study: RandomizEd Trial of ENtERal Glutamine to minimIZE Thermal Injury (RE-ENERGIZE)

Burns

United States, Belgium, Canada, Singapore, Spain, Austria, Brazil, Dominican Republic, Germany, Italy, Paraguay, Sweden, Thailand, United Kingdom
Takeda

Completed

Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years

Healthy

Colombia, Singapore, Thailand, Puerto Rico
Arcturus Therapeutics, Inc.

Terminated

A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults

Covid19 | Corona Virus Infection | SARS-CoV Infection

United States, Singapore
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens (SCULPTURE)

Moderate to Severe Plaque-type Psoriasis

United States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
Novartis Pharmaceuticals

Completed

4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

Moderate to Severe Chronic Plaque-Type Psoriasis

United States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
Novartis Pharmaceuticals

Completed

Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab

Moderate to Severe Plaque-type Psoriasis

Germany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
Galderma R&D

Completed

Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis

United States, Belgium, Bulgaria, Estonia, France, Georgia, Germany, Hungary, Italy, Poland, Singapore
Galderma R&D

Active, not recruiting

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis

United States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom

Clinical Trials on Severe Burns in Singapore

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations